We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Management Changes Make Barclays PLC Investible Again

How managment changes will play out for investors in Barclays PLC (LON:BARC)

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

I used to be a fan of Barclays (LSE: BARC ) (NYSE: BCS.US). The bank has several valuable franchises which should prove to be nuggets of gold, once economic growth feeds through into a healthier banking sector and ‘blame the bankers’ wears thin as an all-purpose political rallying call and perma-excuse. Bob Diamond snapped up a bargain in the form of Lehman Brother’s investment bank; the UK commercial bank is a one-way bet on Britain’s economic fortunes; Barclaycard has a premium competitive position and, to top it all, Barclays’ African business is a frontier market growth play par excellence.

I lost faith in March when CEO Antony Jenkins announced that he had run out of patience with the investment bank. I thought investors would eventually lose patience with him, but there would be much re-strategising and treading water in the meantime.

Should you buy Barclays Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Mr Jenkins seemed a safe — and saintly — pair of hands when the bank was mired in multiple scandals. However, lacking the gall to either bring the American investment bankers to heel or spin off the investment bank wholesale, he resorted to salami-slicing it in the most value-destructive fashion imaginable.

I was premature in my analysis: incoming chairman John McFarlane lost no time ousting Mr Jenkins. So how will the latest management changes play out for investors?

Mack the Knife

Mr McFarlane installing himself as executive chairman is welcome news, certainly if he repeats the fantastic performance he pulled off in similar circumstances at insurer Aviva. Expect a forensic business-unit-by-business-unit strategic analysis, followed by ruthless disposal of ill-fitting units and a slash and burn campaign on costs.

True, Mr Jenkins had not one but two bites at the strategic review cherry and Project Transform was eminently sensible, but paraphrasing Barclays’ own announcements, he ‘lacked the skillset’ to do it fast (or effectively) enough.

It may not be much fun to work for a man whose nickname is ‘Mack the Knife’, but Mr McFarlane appears to have the ability to push strategic decisions through the treacle of middle management whose main raison d’etre in large organisations such as Barclays and Aviva is to preserve their own jobs and fiefdoms. Looking at the way Mr Jenkins was ousted — with deputy chairman Sir Mike Rake presented as having done the dirty deed — I suspect ‘MacHiavelli’ might actually be a better nickname for the new chairman.

Heavy lifting

So, as at Aviva, Mr McFarlane is likely to do the heavy lifting of re-positioning, and then install a competent CEO whose emphasis will be on implementation. That puts current finance director Tushar Morzaria in a good place to step up. With an investment banking background, he might have been the man to face up to the bigwigs of New York, but that didn’t work while he was in the number two slot.

Whoever Mr MacFarlane eventually chooses, it’s likely to be a strong leader who executes rather than debates. One of the most energy-sapping things in large companies is when senior management are constantly questioning and re-visiting strategy, which seems to have been the case under Mr Jenkins.

Indeed if a report in the Financial Times is to be believed, it was an argument over the future of the investment bank between Mr Jenkins and investment bank head Tom King that was the immediate catalyst for Mr Jenkins’ departure, with Mr McFarlane and Sir Mike siding with Mr King.

Sans the saint, Barclays’ investment bank might be viewed as more than just a PR headache. It generates an appallingly low return on capital but it needs fixing, not death by a thousand cuts.

Exit Sir Mike

The bungling of Sir Mike’s hasty departure is illuminating. It’s no surprise that a forceful executive chairman and a forceful deputy chairman (who missed out twice on the top job himself) decided they wouldn’t make comfortable boardroom neighbours. But after the news broke Barclays was forced to stress that Sir Mike would remain until a new CEO is installed. It seems managers at the Prudential Regulatory Authority were uncomfortable with Mr McFarlane ruling the roost with no restraining influences — they have read their Machiavelli, too.

Meanwhile the bank’s shares remain cheap, trading at a 10% discount to tangible net worth. Successful turnarounds need two things: a good underlying business, and good management. If Barclays’ new leadership can get the franchise working again, that share price discount should go to a premium.

Tony Reading has no position in any shares mentioned. The Motley Fool UK has recommended Barclays. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up as a woman counts out modern British banknotes.
Investing Articles

With a 6.4% yield and P/E of 10 is this FTSE dividend stock a hidden passive income gem?

Building a portfolio of solid UK dividend stocks isn't hard. Paul Summers takes a closer look at one high-yielding candidate…

Read more »

Black woman using smartphone at home, watching stock charts.
Growth Shares

At 112p, where next for the Lloyds share price? 168p or 56p?

Jon Smith mulls over the direction going forward for the Lloyds share price, and explains why two very different scenarios…

Read more »

Investing Articles

This dividend stock has a 7.3% yield, and Stocks and Shares ISA investors are buying!

Looking to move from a Cash ISA to a Stocks and Shares ISA to target passive income? Alan Oscroft has…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

Could Rolls-Royce shares lock in another 34% gain before Christmas?

Mark Hartley takes a look at some of the more optimistic price targets for Rolls-Royce, and considers a best-case scenario.…

Read more »

This way, That way, The other way - pointing in different directions
Investing Articles

Investec vs Aberdeen: which is the better income stock to buy?

Aiming to boost the average yield of his income portfolio, Mark Hartley's looking for new income stocks to buy on…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

Down 41% since January, this quality S&P 500 stock is stinking out my ISA

The tide's turned against this S&P 500 robotics stock. Is it time to dump it? Or is there a no-brainer…

Read more »

GSK scientist holding lab syringe
Investing Articles

By mid-2027, analysts expect £6,000 in GSK shares to be worth…

GSK shares are currently trading almost 20% below their 2026 highs. Is there potential for a rebound over the next…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Up nearly 1,400% in 5 years! But are Rolls-Royce shares still secretly undervalued?

After skyrocketing, Rolls-Royce shares are now near an all-time high, but could the engineering giant still have more room to…

Read more »